+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Plasma Therapy - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4845762
The global market for Plasma Therapy was valued at USD 510.6 Million in 2024 and is projected to reach USD 782.5 Million by 2030, growing at a CAGR of 7.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Plasma Therapy Market - Key Trends and Drivers Summarized

Healing from Within: The Promises and Processes of Plasma Therapy

Plasma therapy, also known as platelet-rich plasma (PRP) therapy, is a medical treatment that utilizes the patient's own blood to accelerate healing in various parts of the body. The process begins with a blood draw, from which the plasma, rich in platelets and growth factors, is isolated through centrifugation. This concentrated plasma is then injected into the injured or affected area. Platelets play a crucial role in clotting and tissue repair, and the growth factors they release can stimulate cell proliferation, tissue regeneration, and healing. This therapy is increasingly popular in fields like orthopedics, sports medicine, and dermatology for its potential to enhance recovery and reduce inflammation.

How Is Plasma Therapy Applied in Different Medical Fields?

Plasma therapy is utilized across a range of medical fields due to its regenerative properties. In orthopedics and sports medicine, PRP injections are used to treat chronic tendon injuries, such as tennis elbow and Achilles tendinitis, as well as acute injuries like ligament sprains and muscle strains. These injections can also aid in the recovery from surgeries, enhancing the healing process and reducing downtime. In dermatology, plasma therapy is employed for facial rejuvenation, reducing wrinkles, and improving skin texture through procedures commonly known as the “vampire facial.” Additionally, PRP is used in hair restoration treatments, promoting hair growth in patients experiencing hair loss. The versatility of plasma therapy makes it a valuable tool in both restorative and aesthetic medicine, offering patients a natural and effective treatment option.

What Are the Current Trends in Plasma Therapy Research and Applications?

The field of plasma therapy is continuously evolving, driven by ongoing research and clinical advancements. One significant trend is the increasing use of PRP in combination with other treatments, such as stem cell therapy and microneedling, to enhance therapeutic outcomes. Researchers are also exploring the efficacy of plasma therapy in new areas, such as treating degenerative joint diseases like osteoarthritis and promoting wound healing in diabetic patients. Advances in PRP preparation techniques are improving the consistency and potency of the treatments, making them more reliable and effective. Additionally, there is a growing emphasis on understanding the specific components of PRP and how different concentrations of platelets and growth factors can be optimized for various conditions. These trends reflect the dynamic nature of plasma therapy research, aiming to broaden its applications and improve patient outcomes.

What Factors Are Driving the Growth in the Plasma Therapy Market?

The growth in the plasma therapy market is driven by several factors, reflecting the increasing demand for innovative and effective medical treatments. Rising awareness of the benefits of PRP therapy, coupled with its minimally invasive nature and lower risk of side effects, is attracting more patients and healthcare providers. Technological advancements in PRP preparation and delivery methods are enhancing the efficacy and reliability of treatments, further boosting their popularity. The expanding applications of plasma therapy in diverse medical fields, including orthopedics, dermatology, and hair restoration, are contributing to market growth. Additionally, the growing trend towards regenerative medicine and personalized treatments is driving interest in PRP as a natural and patient-specific therapy. Increased healthcare spending and the expansion of medical infrastructure in developing regions are also supporting market growth, making these advanced treatments more accessible. These factors collectively ensure robust growth in the plasma therapy market, highlighting its significant potential in modern healthcare.

Report Scope

The report analyzes the Plasma Therapy market, presented in terms of market value (USD Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments

Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin); Application (Orthopedics, Dermatology, Dentistry, Other Applications).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Pure PRP segment, which is expected to reach $468.4 Million by 2030 with a CAGR of a 9%. The Leukocyte-Rich PRP segment is also set to grow at 4.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $140.9 Million in 2024, and China, forecasted to grow at an impressive 6.7% CAGR to reach $119.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in USD from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Active Sports Medicine, Alkahest, Inc., Bio Products Laboratory Ltd., Biolife Plasma Services, CSL Ltd. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Plasma Therapy Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Plasma Therapy Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Plasma Therapy Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Some of the 38 major companies featured in this Plasma Therapy market report include:

  • Active Sports Medicine
  • Alkahest, Inc.
  • Bio Products Laboratory Ltd.
  • Biolife Plasma Services
  • CSL Ltd.
  • Excelsior Orthopaedics
  • Glofinn Oy
  • Juventix
  • Octapharma AG
  • Origin, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Plasma Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Chronic Diseases Propels Market Growth
  • Advances in Plasma-Derived Therapies Drives Adoption
  • Rising Demand for Immunoglobulin Therapies Expands Market Opportunities
  • Growth in Geriatric Population Strengthens Business Case for Plasma Therapy
  • Development of Novel Plasma Treatments Spurs Market Expansion
  • Expansion of Blood Plasma Donation Centers Generates Demand
  • Increasing Focus on Personalized Medicine Accelerates Market Growth
  • Enhanced Safety and Efficacy of Modern Plasma Therapies Sustains Market Demand
  • Rising Investments in Plasma Research and Development Expands Addressable Market
  • Technological Innovations in Plasma Fractionation Strengthens Market Position
  • Development of Recombinant Plasma Products Generates Market Opportunities
  • Growth in Hemophilia and Coagulation Disorder Treatments Propels Market Growth
  • Increasing Demand for Convalescent Plasma Therapy Sustains Market Expansion
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Plasma Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 2: World Historic Review for Plasma Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 3: World 15-Year Perspective for Plasma Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Pure PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 5: World Historic Review for Pure PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 6: World 15-Year Perspective for Pure PRP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Leukocyte-Rich PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 8: World Historic Review for Leukocyte-Rich PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 9: World 15-Year Perspective for Leukocyte-Rich PRP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Pure Platelet-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 11: World Historic Review for Pure Platelet-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 12: World 15-Year Perspective for Pure Platelet-Rich Fibrin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Leukocyte-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 14: World Historic Review for Leukocyte-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 15: World 15-Year Perspective for Leukocyte-Rich Fibrin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 16: World Plasma Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • Table 17: World Recent Past, Current & Future Analysis for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 18: World Historic Review for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 19: World 15-Year Perspective for Orthopedics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 21: World Historic Review for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 22: World 15-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Dentistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 24: World Historic Review for Dentistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 25: World 15-Year Perspective for Dentistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Table 29: USA Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 30: USA Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 31: USA 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 33: USA Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 34: USA 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
CANADA
  • Table 35: Canada Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 36: Canada Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 37: Canada 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 38: Canada Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 40: Canada 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
JAPAN
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Table 41: Japan Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 42: Japan Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 43: Japan 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 44: Japan Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 46: Japan 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
CHINA
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Table 47: China Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 48: China Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 49: China 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 50: China Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 51: China Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 52: China 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
EUROPE
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Table 53: Europe Recent Past, Current & Future Analysis for Plasma Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Plasma Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 55: Europe 15-Year Perspective for Plasma Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 58: Europe 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 59: Europe Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 61: Europe 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
FRANCE
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • Table 62: France Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 63: France Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 64: France 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 65: France Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 66: France Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 67: France 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
GERMANY
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • Table 68: Germany Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 69: Germany Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 70: Germany 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 71: Germany Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 72: Germany Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 73: Germany 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
ITALY
  • Table 74: Italy Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 75: Italy Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 76: Italy 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 77: Italy Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 78: Italy Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 79: Italy 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
UNITED KINGDOM
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • Table 80: UK Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 81: UK Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 82: UK 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 83: UK Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 84: UK Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 85: UK 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
REST OF EUROPE
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 87: Rest of Europe Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 88: Rest of Europe 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 90: Rest of Europe Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 91: Rest of Europe 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
ASIA-PACIFIC
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 93: Asia-Pacific Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 94: Asia-Pacific 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 96: Asia-Pacific Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 97: Asia-Pacific 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
REST OF WORLD
  • Table 98: Rest of World Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 99: Rest of World Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 100: Rest of World 15-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2015, 2025 & 2030
  • Table 101: Rest of World Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 102: Rest of World Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 103: Rest of World 15-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2015, 2025 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Active Sports Medicine
  • Alkahest, Inc.
  • Bio Products Laboratory Ltd.
  • Biolife Plasma Services
  • CSL Ltd.
  • Excelsior Orthopaedics
  • Glofinn Oy
  • Juventix
  • Octapharma AG
  • Origin, Inc.

Table Information